These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 28423541)
1. RNA sequencing analysis reveals protective role of kruppel-like factor 3 in colorectal cancer. Wang X; Jiang Z; Zhang Y; Wang X; Liu L; Fan Z Oncotarget; 2017 Mar; 8(13):21984-21993. PubMed ID: 28423541 [TBL] [Abstract][Full Text] [Related]
2. High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer. Chen Z; Wu G; Ye F; Chen G; Fan Q; Dong H; Zhu X; Wu C BMC Cancer; 2019 May; 19(1):448. PubMed ID: 31088409 [TBL] [Abstract][Full Text] [Related]
3. Krüppel-Like Factor 7 is a Marker of Aggressive Gastric Cancer and Poor Prognosis. Jiang Z; Yu T; Fan Z; Yang H; Lin X Cell Physiol Biochem; 2017; 43(3):1090-1099. PubMed ID: 28977783 [TBL] [Abstract][Full Text] [Related]
4. FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients. Li J; Jiang Z; Han F; Liu S; Yuan X; Tong J Oncotarget; 2016 May; 7(18):25585-92. PubMed ID: 27027443 [TBL] [Abstract][Full Text] [Related]
5. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis. Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618 [TBL] [Abstract][Full Text] [Related]
6. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer. Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639 [TBL] [Abstract][Full Text] [Related]
7. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer. Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184 [TBL] [Abstract][Full Text] [Related]
8. Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience. Ahmed S; Fields A; Pahwa P; Chandra-Kanthan S; Zaidi A; Le D; Haider K; Reeder B; Leis A Clin Colorectal Cancer; 2015 Dec; 14(4):e41-7. PubMed ID: 26140732 [TBL] [Abstract][Full Text] [Related]
9. Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival. Linhares MM; Affonso RJ; Viana Lde S; Silva SR; Denadai MV; de Toledo SR; Matos D PLoS One; 2015; 10(12):e0144333. PubMed ID: 26674523 [TBL] [Abstract][Full Text] [Related]
10. GINS complex subunit 4, a prognostic biomarker and reversely mediated by Krüppel-like factor 4, promotes the growth of colorectal cancer. Rong Z; Luo Z; Zhang J; Li T; Zhu Z; Yu Z; Fu Z; Qiu Z; Huang C Cancer Sci; 2020 Apr; 111(4):1203-1217. PubMed ID: 32012389 [TBL] [Abstract][Full Text] [Related]
11. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796 [TBL] [Abstract][Full Text] [Related]
12. Tumor-suppressive role of Kruppel-like factor 4 (KLF-4) in colorectal cancer. Xiu DH; Chen Y; Liu L; Yang HS; Liu GF Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218782 [TBL] [Abstract][Full Text] [Related]
13. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis. Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413 [TBL] [Abstract][Full Text] [Related]
14. MMP14 predicts a poor prognosis in patients with colorectal cancer. Cui G; Cai F; Ding Z; Gao L Hum Pathol; 2019 Jan; 83():36-42. PubMed ID: 30120968 [TBL] [Abstract][Full Text] [Related]
16. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Stanisavljević L; Myklebust MP; Leh S; Dahl O Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662 [TBL] [Abstract][Full Text] [Related]
17. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients. Bae JM; Lee TH; Cho NY; Kim TY; Kang GH World J Gastroenterol; 2015 Feb; 21(5):1457-67. PubMed ID: 25663765 [TBL] [Abstract][Full Text] [Related]
18. c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer. Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS PLoS One; 2015; 10(10):e0139727. PubMed ID: 26426996 [TBL] [Abstract][Full Text] [Related]
19. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer. Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222 [TBL] [Abstract][Full Text] [Related]
20. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer. Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]